BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18668694)

  • 1. Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation.
    Wu CC; Peng PH; Chang YT; Huang YS; Chang KP; Hao SP; Tsang NM; Yeh CT; Chang YS; Yu JS
    Proteomics; 2008 Sep; 8(17):3605-20. PubMed ID: 18668694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
    Wu CC; Chien KY; Tsang NM; Chang KP; Hao SP; Tsao CH; Chang YS; Yu JS
    Proteomics; 2005 Aug; 5(12):3173-82. PubMed ID: 16035111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma.
    Chang YH; Wu CC; Chang KP; Yu JS; Chang YC; Liao PC
    J Proteome Res; 2009 Dec; 8(12):5465-74. PubMed ID: 19845400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
    Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
    Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis.
    Chang KP; Wu CC; Chen HC; Chen SJ; Peng PH; Tsang NM; Lee LY; Liu SC; Liang Y; Lee YS; Hao SP; Chang YS; Yu JS
    Proteomics; 2010 Jul; 10(14):2644-60. PubMed ID: 20461718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for differentially expressed proteins in nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis].
    Yi H; Cheng AL; Huang WG; Zhang PF; Li MY; Peng F; Li F; Li C; Chen ZC; Xiao ZQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):375-83. PubMed ID: 18544839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
    Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
    J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
    Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Yi B; Xiao ZQ
    Clin Cancer Res; 2008 Jan; 14(2):435-45. PubMed ID: 18223218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry--plasma peptidomes from nasopharyngeal cancer patients for example.
    Chang JT; Chen LC; Wei SY; Chen YJ; Wang HM; Liao CT; Chen IH; Cheng AJ
    Clin Biochem; 2006 Dec; 39(12):1144-51. PubMed ID: 17014837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
    J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma.
    Peng PH; Wu CC; Liu SC; Chang KP; Chen CD; Chang YT; Hsu CW; Chang YS; Yu JS
    J Proteomics; 2011 May; 74(5):744-57. PubMed ID: 21376147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
    Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH
    Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.
    Orazine CI; Hincapie M; Hancock WS; Hattersley M; Hanke JH
    J Proteome Res; 2008 Apr; 7(4):1542-54. PubMed ID: 18336003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue polypeptide specific antigen (TPS) as a tumor marker in nasopharyngeal carcinoma.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(6C):4661-3. PubMed ID: 11205197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes.
    Chang KP; Hao SP; Chang JH; Wu CC; Tsang NM; Lee YS; Hsu CL; Ueng SH; Liu SC; Liu YL; Wei PC; Liang Y; Chang YS; Yu JS
    Clin Cancer Res; 2008 Nov; 14(21):6979-87. PubMed ID: 18980993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of a specific serum proteomic profile model of nasopharyngeal carcinoma by MALDI-TOF MS].
    Tao YL; Liu ZG; Xia YF; Yi W
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):188-91. PubMed ID: 21575517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis.
    Tang CE; Tan T; Li C; Chen ZC; Ruan L; Wang HH; Su T; Zhang PF; Xiao ZQ
    Oncol Rep; 2010 Aug; 24(2):495-500. PubMed ID: 20596638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma.
    Chow KC; Chiou SH; Ho SP; Tsai MH; Chen CL; Wang LS; Chi KH
    Oncol Rep; 2003; 10(4):813-9. PubMed ID: 12792728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.